Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$296,087
in 3 filings

Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Rosenthal Arnon −$193K Chief Executive Officer sold 3% of stake
  2. Berkley Neil Lindsay −$78K CFO & Chief Business Officer sold 8% of stake
  3. Wong-Sarad Grace −$25K Principal Accounting Officer sold 8% of stake
Date Insider Transaction Shares Price Value Owned after
2020-04-09 ORBIMED ADVISORS LLC 10% owner Sale −218,208 $23.79 $5.2M 6,020,366
2020-04-09 ORBIMED ADVISORS LLC 10% owner Sale −69,893 $23.79 $1.7M 1,927,440
2020-04-08 ORBIMED ADVISORS LLC 10% owner Sale −62,573 $23.65 $1.5M 6,238,574
2020-04-08 ORBIMED ADVISORS LLC 10% owner Sale −20,041 $23.65 $474K 1,997,333
2020-04-07 ORBIMED ADVISORS LLC 10% owner Sale −6,946 $23.10 $160K 6,301,147
2020-04-07 ORBIMED ADVISORS LLC 10% owner Sale −2,224 $23.10 $51K 2,017,374
2020-03-31 ORBIMED ADVISORS LLC 10% owner Sale −189,355 $24.50 $4.6M 6,308,093
2020-03-31 ORBIMED ADVISORS LLC 10% owner Sale −60,645 $24.50 $1.5M 2,019,598
2020-03-25 ORBIMED ADVISORS LLC 10% owner Sale −42,727 $24.66 $1.1M 6,497,448
2020-03-25 ORBIMED ADVISORS LLC 10% owner Sale −13,684 $24.66 $337K 2,080,243
2020-03-24 ORBIMED ADVISORS LLC 10% owner Sale −51,235 $24.45 $1.3M 6,540,175
2020-03-24 ORBIMED ADVISORS LLC 10% owner Sale −16,409 $24.45 $401K 2,093,927
2020-03-23 ORBIMED ADVISORS LLC 10% owner Sale −11,057 $26.05 $288K 6,591,410
2020-03-23 ORBIMED ADVISORS LLC 10% owner Sale −3,541 $26.05 $92K 2,110,336
2020-03-20 Hammond Paula Director Grant or award · Stock Option (right to buy) +29,443 29,443
2020-03-13 Paul Robert Chief Medical Officer Sale −1,481 $21.57 $32K 262,238
2020-03-13 Paul Robert Chief Medical Officer Sale −2,884 $22.47 $65K 259,354
2020-03-13 Paul Robert Chief Medical Officer Sale −5,459 $23.49 $128K 253,895
2020-03-13 Paul Robert Chief Medical Officer Sale −176 $24.46 $4K 253,719
2020-03-02 ORBIMED ADVISORS LLC 10% owner Sale −1,390,309 $26.00 $36.1M 6,602,467

Page 25 of 36 · 702 trades